<?xml version="1.0" encoding="UTF-8"?>
<p>In fact, clinical trials have commenced to evaluate the optimal timing, duration, and safety of baricitinib in viral infections, including SARS-CoV-2.
 <sup>
  <xref rid="bibr19-1759720X20947296" ref-type="bibr">19</xref>
  <xref rid="bibr20-1759720X20947296" ref-type="bibr"/>â€“
  <xref rid="bibr21-1759720X20947296" ref-type="bibr">21</xref>
 </sup>
</p>
